NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
Loading market information…
NSE · SAILIFE.NS · INR
Stock price, earnings
Quote as of Oct 30, 2026, 10:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Sai Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 8.04% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Sai Life Sciences Limited’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of ₹3.97. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sai Life Sciences Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2024 | May 13, 2025 | ₹4.15+12.16% vs estimate | ₹5.80B+11.21% vs estimate |
|---|
| Q3 2024 | Feb 6, 2025 | ₹2.60 | ₹4.40B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
₹9,780.00+₹116.00 (+1.2%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
₹829.90-₹0.25 (-0.03%)
Anthem Biosciences Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.1% below the high.
₹238.00+₹7.22 (+3.13%)
Piramal Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 0.83% below the high.
₹403.00+₹4.40 (+1.1%)
Syngene International Limited’s quoted price sits in the lower half of its reported 52-week range, 40.64% below the high.
₹501.05-₹2.50 (-0.5%)
Blue Jet Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 27.23% below the high.
₹144.05-₹5.37 (-3.59%)
Dishman Carbogen Amcis Limited’s quoted price sits in the lower half of its reported 52-week range, 52.46% below the high.
₹485.60-₹34.20 (-6.58%)
Vimta Labs Limited’s quoted price sits in the lower half of its reported 52-week range, 33.93% below the high.
